Mechanism of gadophrin-2 accumulation in tumor necrosis

Journal of Magnetic Resonance Imaging

Volumn 9, Issue 2, 1999, Pages 336-341

  Hofmann, Birte ^a,b   Bogdanov Jr , Alexei ^a   Marecos, Edgardo ^a   Ebert, Wolfgang ^c   Semmler, Wolfhard ^b   Weissleder, Ralph ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c BAYER PHARMA AG   (Germany)

Author keywords

Cancer; Gadolinium porphyrin; Porphyrin

Indexed keywords

GADOPHRIN 2; MESOPORPHYRIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DRUG ACCUMULATION; DRUG DISPOSITION; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; INTRAVENOUS DRUG ADMINISTRATION; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; TUMOR NECROSIS;

ANIMALS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MESOPORPHYRINS; METALLOPORPHYRINS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS, EXPERIMENTAL; TISSUE DISTRIBUTION;

EID: 0032967561     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1522-2586(199902)9:2<336::AID-JMRI28>3.0.CO;2-3     Document Type: Article

References (33)

1. Enochs W, Weissleder R. Organ- and tissue-directed MRI contrast agents. In: Edelman R, Hesselink J, Zlatkin M, (editors). Clinical magnetic resonance imaging. Vol. 1. Philadelphia: WB Saunders, 1996. p 192-220.
2. Göhr-Rosenthal S, Schmitt-Willich H, Ebert W, Conrad J. The demonstration of human tumours on nude mice using gadolinium-labelled monoclonal antibodies in magnetic resonance imaging. Invest Radiol 1993;28:789-795.
3. Ebert W, Hofmann S, Swiderski U. et al. Metalloporphyrins: tumor specific contrast agents? In: Rinck PA, Muller RN, editors. New developments in contrast agent research, 1993. Proceedings of the 3rd Special Topic Seminar of the European Magnetic Resonance Forum, Hamburg, Germany, September 23-25, 1992. p 127-140.
4. Kessel D. Porphyrin localization: a new modality for detection and therapy of tumors. Biochem Pharmacol 1984;33:1389-1393.
5. Figge F, Weiland G, Manganiello L. Cancer detection and therapy. Affinity of neoplastic, embryonic, and traumatized tissues for porphyrins and metalloporphyrins. Proc Soc Exp Biol Med 1948;68:640-641.
6. Furmanski P, Logley C. Metalloporphyrin enhancement of magnetic resonance imaging of human tumor xenografts in nude mice. Cancer Res 1988;48:4604-4610.
7. Ogan M, Revel D, Brasch RC. Metalloporphyrin contrast enhancement of tumors in magnetic resonance imaging: A study of human carcinoma, lymphoma, and fibrosarcoma in mice. Invest Radiol 1987;22:822-828.
8. Hilger C, Maier F, Ebert W, et al. German Patent Application DE 42 32 925 A1, September 28, 1992
9. Ni Y, Marchal G, Yu J, et al. Localization of metalloporphyrin induced "specific" enhancement in experimental liver tumors: comparison of magnetic resonance imaging, microangiographic, and histologic findings. Acad Radiol 1995;2:687-699.
10. Marchal G, Ni Y, Herijgers P, et al. Pharmagnetic metalloporphyrins: infarct avid contrast agents for diagnosis of acute myocardial infarction by MRI. Eur Radiol 1996;6:2-8.
11. Ward B, Skorobogaty A, Dabrowiak JC. DNA binding specificity of a series of cationic metalloporphyrin complexes. Biochemistry 1986; 25:7827-7833.
12. Sehlstedt U, Kim K, Carter P, et al. Interactions of cationic porphyrins with DNA. Biochemistry 1994;33:417-426.
13. Jain JK. Transport of molecules in the tumor interstitium: a review. Cancer Res 1987;47:3039-3051.
14. Dvorak H. Leaky tumor vessels: consequences for tumor stromageneration and for solid tumor therapy. Prog Clin Biol Res 1990;354A: 317-330.
15. Barnett A, Roman-Goldstein S, Ramsey F, et al. Differential permeability and quantitative MR imaging of a human lung carcinoma brain xenograft in a nude rat. Am J Pathol 1992;146:436-449.
16. Ritschel W. Handbook of basic pharmacokinetics. 3rd ed. Hamilton. IL: Drug Intelligence Publications; 1986.
17. Garfin E. One-dimensional gel electrophoresis. Vol. 182 Methods in Enzymology: Guide to Protein Purification. San Diego, CA: Academic Press; 1990.
18. Outhred RK, George EP. A nuclear magnetic resonance study of hydrated systems using the frequency dependence of the relaxation progresses. Biophys J 1973;13:83-96.
19. Koenig SH, Brown R III. Relaxation of solvent protons of paramagnetic ions; dependence on magnetic field and chemical environment: implication for NMR imaging. Magn Reson Med 1984;1:478-495.
20. Yushmanov VE, Tominaga TT, Borissevitch IE. Imasato H, Tabak M. Binding of manganese and iron tetraphenylporphyrine sulfonates to albumin is relevant to their contrast properties. Magn Reson Imaging 1996;14:255-261.
21. Beri R, Chandra R. Chemistry and biology of heme: effect of metal salts, organometals, and metalloporphyrins on heme synthesis and catabolism, with special reference to clinical implications and interactions with cytochrome P-450. Drug Metab Rev 1993;25:49-152.
22. Nelson J, Schmied U. Porphyrins as contrast media. Magn Reson Med 1991;22:366-371.
23. Pass H. Photodynamic therapy in oncology: mechanisms and clinical use. J Natl Cancer Inst 1993;85:443-456.
24. Policard A. Etude sur les aspects offerts par des tumeurs expérimentales examinées à la lumiére de Wood. CR Soc Biol 1924;91:1423-1424.
25. Oenbrink G, Juergenlinke P, Gabel D. Accumulation of porphyrins in cells: influence of hydrophobicity aggregation and protein binding. Photochem Photobiol 1988;48:451-456.
26. Fiel R, Mark E, Button T, Gilani S, Musser D. Mechanism of localization of manganese (III) meso-tetra(4-sulfonatophenyl) porphine in mice bearing L1210 tumors. Cancer Lett 1988;40:23-32.
27. Hill J, Kahl S, Kaye A, et al. Selective tumor uptake of a boronated porphyrin in an animal modal of cerebral glioma. Proc Natl Acad Sci 1992;89:1785-1789.
28. Snyder S, Verma A, Trifiletti R. The peripheral-type benzodiazepine receptor: a protein of mitochondrial outer membranes utilizing porphyrins as endogenous ligands. FASEB J 1987;1:282-288.
29. Starosta-Rubinstein S, Ciliax B, Penney J, McKeever P, Young A. Imaging of a glioma using peripheral benzodiazepine receptor ligands. Proc Natl Acad Sci 1987;84:891-895.
30. Nelson J, Schmiedl U, Shankland E, Metalloporphyrins as tumor-seeking MRI contrast media and as potential selective treatment sensitizers. Invest Radiol 1990;25:S71-S73.
31. Hindré F, Le Ploezennec M, de Certaines J, Foultier M, Patrice T, Simonneaux G. Tetra-p-aminophenylporphyrin conjugated with Gd-DTPA: tumor-specific contrast agent for MR imaging. J Magn Reson Imaging 1993;3:59-65.
32. 4. Invest Radiol 1992;27:536-542.
33. Bugelski P, Porter C, Dougherty T. Autoradiographic distribution of hematoporphyrin derivative in normal and tumor tissue of the mouse. Cancer Res 1981;41:4606-4612.